Can I use Activelle with BIRADS 3?

On a scale developed by the American Society of Radiology, a BI-RADS 3 score means a study in which a lesion that is likely to benign has been detected, however, the risk of malignancy is up to 2%. With such results, it is recommended to control in 6 months. The detected lesion can be a microcalcification, cyst, fibroadenoma, a kind of tissue compaction. In patients at increased risk of developing breast cancer who have such a result, the doctor may recommend a biopsy and collection of material for histopathological examination. As for Activelle, hormone replacement therapy may increase the risk of breast cancer. It depends on how long the patient has been using HRT - the additional risk is revealed after 3 years of using hormones, and after the end of therapy it decreases over time. It is important for the patient using Activelle to inform the test person before the examination about the use of hormone replacement therapy, as this drug may increase breast density and affect the result of the mammography examination. Breast cancer is a contraindication to the use of Activelle and other types of hormone replacement therapy. However, you have not been diagnosed with cancer at this stage, but with a high probability of benign change, but requiring additional monitoring. In this situation, I cannot comment for a doctor on how he will assess the benefit-risk balance in your case. You should contact a gynecologist with the result without undue delay. I enclose additional information about Activelle and hormone replacement therapy: https://www.gdziepolek.pl/produkty/2171/activelle-tabletki-powlekane/apteki/w-warszawie https://www.gdziepolek.pl/artykuly/htz-hormonalna-terapia-zastepcza-w-menopauzie